13F-HR/A filed by Melqart Asset Management (UK) Ltd
Melqart Asset Management (UK) Ltd filed this 13F-HR/A for the quarter ended 2019-12-31, filed 2020-02-14, with 40 holding rows worth $1,193,617,000.
- Accession
- 0001172661-20-000759
- Filer
- CIK 1712901
- Filed
- 2020-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2019
A holdings report, amendment of type restatement, 40 entries on the cover page, a total value of $1,193,617,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,193,617,000 with VALUE read as thousands by filing date, 13F file number 028-18520. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALLERGAN PLC | G0177J108 | SHS | 704,000 | $134,584,000 | thousands by filing date | |
| NXP SEMICONDUCTORS N V COM | N6596X109 | Stock | 764,935 | $97,346,000 | thousands by filing date | |
| CYPRESS SEMICONDUCTOR CORP | 232806109 | COM | 3,413,000 | $79,625,000 | thousands by filing date | |
| ZAYO GROUP HLDGS INC COM | 98919V105 | Stock | 2,201,000 | $76,265,000 | thousands by filing date | |
| IAC INTERACTIVECORP | 44919P508 | COM | 268,462 | $66,877,000 | thousands by filing date | |
| MELLANOX TECHNOLOGIES LTD | M51363113 | COMMON STOCK | 547,088 | $64,108,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 287,900 | $63,036,000 | thousands by filing date | |
| WABCO HLDGS INC | 92927K102 | COM | 383,000 | $51,897,000 | thousands by filing date | |
| TIFFANY & CO NEW | 886547108 | COM | 351,500 | $46,978,000 | thousands by filing date | |
| WRIGHT MED GROUP N V | N96617118 | ORD SHS | 1,369,000 | $41,727,000 | thousands by filing date | |
| AVAYA HLDGS CORP | 05351X101 | COM | 3,050,000 | $41,175,000 | thousands by filing date | |
| INTERXION HOLDING N.V | N47279109 | SHS | 480,000 | $40,229,000 | thousands by filing date | |
| LOGMEIN INC | 54142L109 | COMMON STOCK | 406,750 | $34,875,000 | thousands by filing date | |
| HILTON GRAND VACATIONS INC COM | 43283X105 | Stock | 954,200 | $32,815,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 374,200 | $31,785,000 | thousands by filing date | call |
| TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS | 874060205 | ADR | 1,557,000 | $30,720,000 | thousands by filing date | |
| TECH DATA CORP | 878237106 | COM | 185,000 | $26,566,000 | thousands by filing date | |
| INSTRUCTURE INC | 45781U103 | COM | 431,660 | $20,810,000 | thousands by filing date | |
| QIWI PLC | 74735M108 | SPON ADR REP B | 1,066,026 | $20,638,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 239,000 | $20,301,000 | thousands by filing date | |
| CISION LTD | G1992S109 | SHS | 1,975,000 | $19,691,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 115,404 | $16,055,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 230,000 | $13,763,000 | thousands by filing date | put |
| RINGCENTRAL INC | 76680R206 | CL A | 74,413 | $12,551,000 | thousands by filing date | |
| QIAGEN NV | N72482123 | SHS NEW | 370,600 | $12,526,000 | thousands by filing date | |
| ATLASSIAN CORP | G06242104 | CL A | 103,000 | $12,395,000 | thousands by filing date | |
| TWILIO INC CL A | 90138F102 | Stock | 120,000 | $11,794,000 | thousands by filing date | |
| CLEVELAND-CLIFFS INC NEW COM | 185899101 | Stock | 1,382,550 | $11,530,000 | thousands by filing date | |
| FARFETCH LTD | 30744W107 | ORD SH CL A | 1,089,000 | $11,271,000 | thousands by filing date | |
| FITBIT INC | 33812L102 | CL A | 1,484,385 | $9,752,000 | thousands by filing date | |
| QUINTANA ENERGY SVCS INC | 74875T103 | COM | 3,288,449 | $9,241,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 369,646 | $7,378,000 | thousands by filing date | |
| BRISTOL-MYERS SQUIBB CO | 110122157 | RIGHT 99/99/9999 | 1,799,100 | $5,415,000 | thousands by filing date | |
| FIVE9 INC | 338307101 | COM | 69,000 | $4,525,000 | thousands by filing date | |
| INTELSAT S A | L5140P101 | COM | 560,403 | $3,940,000 | thousands by filing date | |
| INTELSAT S A | L5140P101 | COM | 410,500 | $2,886,000 | thousands by filing date | call |
| AVAYA HLDGS CORP | 05351XAB7 | NOTE 2.250% 6/1 | 2,600,000 | $2,310,000 | thousands by filing date | principal |
| CYRUSONE INC | 23283R100 | COM | 34,782 | $2,276,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 17,900 | $1,071,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 44,600 | $890,000 | thousands by filing date | put |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-20-000495 | superseded | 2020-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001172661-20-000759 | this filing | 2020-02-14 | acceptance time not in the bulk data set |